(2026). Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, OvMANE1: Preclinical evaluation in a mice model. Clinical & Translational Immunology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Safety and Immunogenicity of an Adjuvanted Human Onchocerciasis Vaccine Candidate, OvMANE1: Preclinical Evaluation in a Mice Model."
Clinical & Translational Immunology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Safety and Immunogenicity of an Adjuvanted Human Onchocerciasis Vaccine Candidate, OvMANE1: Preclinical Evaluation in a Mice Model."
Clinical & Translational Immunology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.